Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 119 citing STIEHM: Interferon: Immunobiology and clinical significance. (0.08 sec) 

A survey of adverse events in 11 241 patients with chronic viral hepatitis treated …


G Fattovich, G Giustina, S Favarato, A Ruol… - Journal of hepatology, 1996 - Elsevier
Results: Five patients died during interferon therapy due to liver failure (n=4) or complications
arising from sepsis. Life-threatening side effects were observed in eight patients: two cases where
depression developed and led to a suicide attempt and six patients with bone marrow ...
Cited by 290 - Related articles - BL Direct - All 3 versions

A randomized controlled trial of lymphoblastoid interferon-a in patients with chronic …


G Fattovich, P Farci, M Rugge, L Brollo, A Mandas, … - Hepatology, 1992 - interscience.wiley.com
Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed
in patients with active liver disease. These forms of chronic hepatitis B have been described
as having a poor prognosis. We have conducted a randomized controlled trial to assess ...
Cited by 156 - Related articles - All 3 versions

AIDS-related malignancies: the emerging epidemic

- oxfordjournals.org [PDF] 
AM Levine - JNCI Journal of the National Cancer Institute, 1993 - jnci.oxfordjournals.org
The incidence of three malignancies has increased in conjunction with the epidemic of human
immunodefi- ciency virus (HIV) disease, and they are currently considered acquired immunodeficiency
syndrome (AIDS)- defining conditions. These are Kaposi's sarcoma, associ- ated with ...
Cited by 130 - Related articles - BL Direct - All 5 versions

Intralesional recombinant alpha-2 interferon for the treatment of patients with …


JC Vance, BJ Bart, RC Hansen, RC … - Archives of …, 1986 - archderm.highwire.org
\s=b\We conducted a multicenter double-blind study com- paring human recombinant intralesional
alpha-2 interfer- on (IFN) and placebo in 237 patients with the clinical diagnosis of condyloma
acuminatum or verruca plantaris. A single wart on each patient was injected with 0.1mL ...
Cited by 119 - Related articles - All 4 versions

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma*


EA Olsen, ST Rosen, RT Vollmer, D Variakojis, HH … - Journal of the American …, 1989 - Elsevier
Twenty-two patients with Stages la to IVa cutaneous T cell lymphoma were entered into a controlled
trial of interferon alfa-2a (Roferon-A). Patients initially received either 3 million IU interferon
alfa-2a, or their dosage was escalated to 36 million IU intramuscularly daily for a 10-week ...
Cited by 116 - Related articles - All 5 versions

Treatment of basal cell carcinoma with intralesional interferon


HT Greenway, RC Cornell, DJ Tanner, E Peets, GM … - Journal of the American …, 1986 - Elsevier
Eight patients with basal cell carcinomas were treated with recombinant alpha-2 interferon. Each
patient had a biopsy-proved basal call carcinoma of the nodular or superficial type that was injected
intralesionally three times a week for 3 weeks (9 total injections) with 1.5 × 10 6 IU (0.15 ...
Cited by 115 - Related articles - All 5 versions

Psoriasis induced by interferon-alpha


J Funk, T Langeland, E Schrumpf, LE Hanssen - Br J Dermatol, 1991 - interscience.wiley.com
SummaryRecombinant human interferon-α has been used in the treatment of several
cancers, but there have been several reports that it may exacerbate psoriasis or trigger off its
onset. We report four patients, three of whom first developed psoriasis and one who had ...
Cited by 78 - Related articles - All 3 versions

Pulmonary sarcoidosis following interferon therapy for advanced renal cell …


EA Abdi, GK Nguyen, RN Ludwig, WJ … - CA A Cancer Journal for … - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 75 - Related articles - All 4 versions

Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired …


EP Gelmann, OT Preble, R Steis, HC Lane, AH … - The American journal of …, 1985 - Elsevier
Thirty consecutive patients with the acquired immune deficiency syndrome were treated with
intramuscular human lymphoblastoid interferon for Kaposi's sarcoma. Patients were divided
Into three groups receiving 7.5 million units/m 2 per day, 15 million units/m 2 per day, or ...
Cited by 68 - Related articles - All 3 versions

Identification of the hepatitis B virus factor that inhibits expression of the beta …

- nih.gov [PDF] 
TM Whitten, AT Quets, RH Schloemer - Journal of virology, 1991 - Am Soc Microbiol
JOURNAL OF VIROLOGY, Sept. 1991, p. 4699-4704 0022-538X/91/094699-06$02.00/0 Copyright
© 1991, American Society for Microbiology ... THOMAS M. WHITTEN, ANNE T. QUETS, AND
ROBERT H. SCHLOEMER* Department ofMicrobiology and Immunology, Indiana
Cited by 58 - Related articles - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google